GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System

Zacks11-15

GE HealthCare Technologies GEHC recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This new innovative ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483384764?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ecFYZtqvCgQ1G__HXA8vTQ--~B/aD0zNDM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574","is_english":true,"pubTime":"2024-11-15 00:10","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483384764","market":"us","top_or_hot":-1,"title":"GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System","media":"Zacks","content":"<div>\n<p>GE HealthCare Technologies GEHC recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.\nThis new innovative ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gehc-stock-falls-despite-fda-161000778.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 00:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/gehc-stock-falls-despite-fda-161000778.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GE HealthCare Technologies GEHC recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.\nThis new innovative ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gehc-stock-falls-despite-fda-161000778.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://finance.yahoo.com/news/gehc-stock-falls-despite-fda-161000778.html","article_id":"2483384764","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ecFYZtqvCgQ1G__HXA8vTQ--~B/aD0zNDM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483384764","pubTimestamp":1731600600,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"GE HealthCare Technologies GEHC recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging  scanner.This new innovative system has the potential to help detect neurological, oncological and psychiatric conditions by providing new clinical imaging and neuroscience capabilities. With SIGNA MAGNUS, GEHC is likely to provide neuroradiologists and neuroscience researchers with a tool that supports advanced imaging and biomarker research.More on the Features & Benefits of GEHC’s SIGNA MAGNUS 3.0T MRI System. The asymmetrical design of the SIGNA MAGNUS 3.0T MRI System shifts the gradient isocenter to the patient edge of the coil rather than its geometric center, enabling patient head access and avoiding shoulder width constraints. This head-only design allows MAGNUS to deliver a gradient amplitude and slew rate far surpassing those of conventional 60cm or 70cm bore whole-body MRI systems, marking a significant advancemen","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","PET":"Wag! Group Co","BK4192":"特殊消费者服务","BK4583":"猴痘概念","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","BK4196":"保健护理服务","DGX":"奎斯特诊疗","BK4567":"ESG概念","BK4588":"碎股","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","RDNT":"RadNet","GEHC":"GE HEALTHCARE TECHNOLOGIES INC","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","ANGO":"阿吉奥动态","BK4082":"医疗保健设备","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC"},"translate_title":"尽管FDA批准SIGNA MAGNUS MRI系统，GEHC股价仍下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDNT":1,"PET":1,"GEHC":1,"ANGO":1,"DGX":0.9},"content_text":"GE HealthCare Technologies GEHC recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.\nThis new innovative system has the potential to help detect neurological, oncological and psychiatric conditions by providing new clinical imaging and neuroscience capabilities. With SIGNA MAGNUS, GEHC is likely to provide neuroradiologists and neuroscience researchers with a tool that supports advanced imaging and biomarker research.\nLikely Trend of GEHC Stock Following the News\nFollowing the announcement, shares of the company moved nearly 0.8% south to $84.18 at yesterday’s close. However, in the year-to-date period, GEHC shares have rallied 8.8% compared with the industry’s 14.5% growth. The S&P 500 increased 26% in the same time frame.\nMeanwhile, GEHC currently has a market capitalization of $38.8 billion. It has an earnings yield of 5.1%, which is much higher than the industry’s yield of 1.2%. In the last reported quarter, GEHC delivered an earnings surprise of 7.6%.\nImage Source: Zacks Investment Research\nMore on the Features & Benefits of GEHC’s SIGNA MAGNUS 3.0T MRI System\nThe asymmetrical design of the SIGNA MAGNUS 3.0T MRI System shifts the gradient isocenter to the patient edge of the coil rather than its geometric center, enabling patient head access and avoiding shoulder width constraints. This head-only design allows MAGNUS to deliver a gradient amplitude and slew rate far surpassing those of conventional 60cm or 70cm bore whole-body MRI systems, marking a significant advancement in MRI technology for neuroimaging applications.\nShorter scan periods and ultra-high anatomical resolution are made possible by the SIGNA MAGNUS system's improved capabilities. Through developments like Oscillating Gradient Diffusion Encoding, it is possible to observe brain function, microstructure and microvasculature, a capability that can be crucial for neurological oncology.\nGEHC intends to use SIGNA MAGNUS' high-gradient performance to enable sophisticated research scanning, including slow cerebral spinal fluid flow measurement, high B-value diffusion imaging and fMRI for examining the blood oxygen level-dependent response. This is likely to be one of the revolutionary advancements in the field of neuroscience research.\nSIGNA MAGNUS is likely to be available for both forward production and upgrades from compatible SIGNA Premier systems. The existing facilities can upgrade to this advanced technology, expanding access to high-performance imaging without the need for entirely new systems, additional power or cooling.\nMore on the HyperG Gradient Technology\nWith the introduction of HyperG gradients, one of the most effective gradient coils available in the SIGNA MAGNUS system, GE HealthCare demonstrated leadership in high-performance gradient technology. The HyperG gradient coil's new asymmetric head-only design maximizes the system's gradient performance for clinical and research scanning by causing substantially less peripheral nerve stimulation.\nThe HyperG gradient technology enables faster image acquisition using the same power requirement as the whole-body SIGNA Premier 3.0T system. Improved gradient strengths lead to enhanced spatial resolution and image clarity. This can result in accurate diagnoses, allowing healthcare providers to detect subtle abnormalities and provide better treatment options.\nFavorable Industry Prospects for GEHC\nPer a report by Future Market Insight, the global brain imaging and neuroimaging market was estimated to be $13.7 billion in 2023 and is anticipated to surpass $22.4 billion by 2033 at a CAGR of 5.1%.\nThe brain imaging and neuroimaging market is driven by the rising incidence and prevalence of neurological disorders, increased awareness of neurodegenerative diseases, an increase in traumatic brain injuries and increased applications of brain imaging and neuroimaging in clinical trials.\nGiven the market potential, the latest FDA clearance of the SIGNA MAGNUS 3.0T MRI System is likely to provide a boost to GEHC’s imaging business.\nGEHC’s Recent Developments in Imaging Space\nIn October, GEHC completed the acquisition of Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business. This transaction is aimed at improving GEHC’s AI-driven image analysis tools, which are designed to make ultrasound diagnosis smarter and more efficient by enhancing image recognition and streamlining workflows.\nIn September, GEHC’s MIM Software announced the receipt of FDA clearance for performing Centiloid scaling for positron emission tomography (PET)-based amyloid imaging analysis and quantification. With MIMneuro, a vendor-neutral solution, this new Centiloid scale tool is likely to be able to assist physicians in more accurately determining the density of amyloid plaque in a patient's brain. Amyloid PET radiotracers help visualize amyloid plaque density in patients evaluated for Alzheimer’s disease.\nGE HealthCare’s Zacks Rank & Stocks to Consider\nGEHC carries a Zacks Rank #3 (Hold) at present.\nSome better-ranked stocks in the broader medical space are AngioDynamics ANGO, Quest Diagnostics DGX and RadNet RDNT. Each stock presently carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nANGO’s earnings surpassed estimates in three of the trailing four quarters and missed once, delivering an average surprise of 31.71%.AngioDynamics’ shares have lost 19.2% year to date against the industry’s6.1% growth.\nQuest Diagnostics has an estimated long-term growth rate of 6.8%. DGX's earnings surpassed estimates in each of the trailing four quarters, with an average surprise being 3.3%.\nQuest Diagnostics has gained 42% year to date compared with the industry's 14.9% growth.\nRadNet’s earnings surpassed estimates in the trailing four quarters, the average surprise being 98.2%.\nRDNT shares have risen 93.7% year to date compared with the industry’s 14.8% growth.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAngioDynamics, Inc. (ANGO) : Free Stock Analysis Report\nQuest Diagnostics Incorporated (DGX) : Free Stock Analysis Report\nRadNet, Inc. (RDNT) : Free Stock Analysis Report\nGE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483384764"}